FDA

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
Chris Lange
Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye disease.
Chris Lange
Stealth Bio stock more than doubled on Tuesday after the company announced a critical update from the FDA.
Chris Lange
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.
Jon C. Ogg
Karyopharm Therapeutics shares made a handy gain on Wednesday after the firm secured a key FDA nod for its relapsed or refractory diffuse large B-cell lymphoma treatment.
Chris Lange
Agile Therapeutics shares took a dip on Tuesday after the company announced a key FDA approval for its new weekly contraceptive patch. Yet, one analyst sees great long-term potential, targeting the...
Chris Lange
Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut allergy treatment.
Chris Lange
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Jon C. Ogg
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
Jon C. Ogg
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.
Chris Lange
Durect shares dropped early on Friday after an FDA committee vote on Posimir, the company’s pain relief treatment.
Chris Lange
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Chris Lange
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Chris Lange
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
Chris Lange